Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Sep 11, 2026, 3:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–14 of 14 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: 162mg Aspirin Clear all

Conditions: Preeclampsia Possible
Interventions: Aspirin; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Preterm Birth, Preeclampsia
Interventions: Daily aspirin (ASA), Split dose aspirin (ASA); Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 16 Years to 55 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Preeclampsia
Interventions: acetylsalicylic acid; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: New York, New York

Conditions: Preeclampsia
Interventions: 162mg aspirin dose; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Preterm Delivery, Obstetrical Complications
Interventions: 162mg Aspirin, 81mg Aspirin; Drug
Lead sponsor: The George Washington University Biostatistics Center; Other
Eligibility: 14 Years and older · Female only
Enrollment: 1,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 14
States / cities: Birmingham, Alabama • San Francisco, California • Chicago, Illinois + 10 more

Conditions: Hypertensive Disorders of Pregnancy, Preeclampsia, Gestational Hypertension
Interventions: Aspirin 81 mg, Aspirin 162 mg; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 14 Years to 35 Years · Female only
Enrollment: 10,742 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 16
States / cities: Birmingham, Alabama • Los Angeles, California • San Francisco, California + 13 more

Conditions: Preeclampsia, Pregnancy Related
Interventions: Aspirin 81Mg Ec Tab, Aspirin 162Mg Ec Tab; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Obstructive Pulmonary Function, Restrictive Pulmonary Function
Interventions: single dose (100 mg) of ASA, single dose (162 mg) of non-enteric-coated chewable aspirin tablets; Drug
Lead sponsor: Vectura, Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 4
States / cities: Orlando, Florida • Winter Park, Florida • Baltimore, Maryland + 1 more

Conditions: Platelet Aggregation Inhibitors
Interventions: Aspirin; Drug
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years to 55 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Falls Church, Virginia

Conditions: Preeclampsia
Interventions: Aspirin, Placebo; Drug
Lead sponsor: Anna Stanhewicz, PhD; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Preterm Birth Complication, Preterm Birth, Preterm Birth Recurrence, Preeclampsia, Preeclampsia (PE), Hypertensive Disorders of Pregnancy, Support Program, Stress, Resilience, Psychological, Empowerment, Patient, Emotional Stress, Pregnancy, Pregnancy Complications, Pregnancy Induced Hypertension, Neonates and Preterm Infants, Cervical Insufficiency, Social Determinants of Health (SDOH), Cervical Shortening, Disparities in Pregnancy Complications, Disparities, Prenatal Care, Care Coordination
Interventions: Care coordination, Electronic massage, support gift #1, Support gift #2, Support gift #3, Support gift #4, Additional PTBCARE+ support, Stress reduction toolkit - Visit 1 (V1), PTBCARE+ mobile application (app) and website, Sleep, meditation, and Wellness app, Emergency low blood sugar kit, Low dose aspirin (LDA), Visit #2 Stress Reduction Toolkit; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,228 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Aspirin 81mg, Aspirin 162 mg, Aspirin 325mg; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Healthy Volunteers
Interventions: ASA, non-enteric-coated chewable aspirin; Drug
Lead sponsor: Vectura, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Baltimore, Maryland • Springfield, Missouri

Conditions: Pre-Eclampsia
Interventions: Acetylsalicylic Acid 81 mg, Acetylsalicylic Acid 162 mg, Control; Drug · Other
Lead sponsor: John O'Brien, MD; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Lexington, Kentucky

Search by objective public record fields.

Aspirin Dosing in Pregnancy

Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)

Low Doses of Aspirin in the Prevention of Preeclampsia

The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia

Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients

Study to Compare the Pharmacokinetics and Pharmacodynamics of ASA Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Adult Subjects With Obstructive or Restrictive Pulmonary Function

Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin

Daily Aspirin Treatment After Preeclampsia

Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities

Trial to Determine Effective Aspirin Dose in COPD

Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.

Role of ASpirin in Placental and Maternal Endothelial Cell Regulation IN Pre-eclampsia